Latest filing published 20 Aug 2026 for Keros Therapeutics, Inc., €32k. Read the official filing
Lorena Raquel Lerner is a declared insider of Keros Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 18 February 2026 and 18 August 2026, the trades on record add up to 2 filings.
No open-market purchase appears, only 2 sales worth €85k.
On 20 August 2026 came the latest disclosure, an open-market sale for €32k in Keros Therapeutics, Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations